| CLENE INC. NEW O.N. |
| USA |
| Gesundheit |
| US1856342019 / A40G3Z |
| 84C0 (Frankfurt) / CLNN (NASDAQ) |
| FRA:84C0, ETR:84C0, 84C0:GR, NASDAQ:CLNN |
| - |
| https://clene.com/ |
|
Clene Inc. is a biopharmaceutical company that focuses on the development of nanotechnology-based therapies for neurodegenerative diseases. Its primary purpose is to innovate and advance treatment options for conditions such as multiple sclerosis, am..
>Volltext.. |
| 61.7 Mio. EUR |
| 75.77 Mio. EUR |
| 0.17 Mio. EUR |
| -18.42 Mio. EUR |
| -22.33 Mio. EUR |
| -2.22 EUR |
| 18.49 Mio. EUR |
| 4.43 Mio. EUR |
| -15.86 Mio. EUR |
| 0.48 |
| -41.52% |
| 33.57% |
| - |
| - |
| - |
| CLENE |
| 04.05.26 |
|